Developer docs
API playgroundTry for free, no card

Search company profiles

iParamed

Full company profile

uuid004nui1

Namestring
iParamed
Legal namestring
BioSenses
Websiteurl
iparamed.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

iParamed, operating commercially under the BioSenses brand, is a Vietnam-based medical technology company that builds an Internet of Medical Things (IoMT) platform for continuous remote patient monitoring. The platform connects FDA- and CE-certified medical devices (ECG Holter, SpO2, blood pressure) to a cloud backend that synchronizes vital-sign data in real time, feeding patient-facing apps, a clinician portal, and early-warning alerts. The core technology originated during COVID-19 as a research collaboration with OUCRU (Oxford University Clinical Research Unit) and was deployed across hundreds of ICU beds, accumulating 30,000+ hours of analyzed vital-sign data and 2,000+ clinical monitoring sessions.

The company packages the underlying platform into five commercial solution lines — BIO SLEEPCARE (sleep apnea screening), BIO RHYTHM (continuous cardiovascular monitoring and risk stratification), BIO CARDICARE (multi-device cardiac and exercise screening), BIO TELECARE (remote tele-monitoring programs), and BIO RESEARCH (clinical research data platform) — and sells them as a bundled offering of hardware, software subscription, and clinical implementation services. Go-to-market is direct enterprise sales to Vietnamese hospitals and specialty clinics (sleep centers, cardiology, respiratory), supported by an advisory board of senior Vietnamese clinicians and a website-driven inside-sales funnel with 24-hour follow-up.

The business is privately held, headquartered in Vietnam, with 7 employees and no disclosed external funding, parent company, or revenue figures. Customer logos are limited (FPT Polytechnic, MedArmor, Nguyen Trai Hospital), and the full device ecosystem carries FDA, CE, and Vietnam Ministry of Health approvals — a regulatory posture that, while heavyweight for a company of this size, also signals readiness for any eventual geographic expansion beyond the single domestic market currently served.

Short descriptiontext

iParamed (BioSenses) is a Vietnam-based health-tech company that operates an FDA- and CE-certified IoMT platform for continuous remote patient monitoring, selling bundled hardware, software, and clinical services to hospitals and specialty clinics in Vietnam.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
remote patient monitoring, IoMT platform, clinical telemedicine, vital sign monitoring, connected medical devices
Industry5 codes
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAH
Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Remote Patient Monitoring
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of FDA, CE certified medical devices including ECG Holter, SpO2 monitors, and blood pressure devices integrated with the platform

biosenses.vn
2Software Platform Subscription
TypeSubscription Recurring
Description

Cloud-based platform subscription for remote patient monitoring, data analysis, and clinical support services

biosenses.vn
3Professional Services
TypeProfessional Services
Description

Clinical implementation support, training, and professional services for healthcare facilities deploying remote monitoring solutions

biosenses.vn
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

iParamed (operating as BioSenses) provides an IoMT (Internet of Medical Things) remote health monitoring platform that integrates FDA/CE-certified medical devices (ECG Holter, SpO2, blood pressure monitors) with cloud-based software for real-time vital sign collection, synchronization, and clinical decision support. The platform enables continuous patient monitoring across hospitals, specialty clinics, and home environments, with bundled solutions covering sleep apnea screening, cardiac monitoring, tele-monitoring, and clinical research.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 30,000+ hours of ECG and vital sign data analyzed
+2 more records
Product overview1 text field

iParamed, through its BioSenses platform, operates as a unified remote health monitoring ecosystem combining medical devices, IoMT connectivity, and cloud-based data management. The platform consists of a core BioSenses platform with multiple specialized solutions: BIO SLEEPCARE™ for sleep apnea screening, BIO RHYTHM™ for continuous cardiovascular monitoring, BIO CARDICARE™ for multi-device cardiac screening, BIO TELECARE™ for tele-monitoring programs, and BIO RESEARCH™ for clinical research. The closed-loop ecosystem connects medical devices to a unified platform enabling real-time vital sign collection and synchronization, supporting healthcare facilities in maintaining continuous patient monitoring from clinic to home.

Product and service1 record
1BioSenses Platform
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

OUCRU (Đơn vị Nghiên cứu Lâm sàng của Đại học Oxford) partnered with iParamed during COVID-19 to develop remote patient monitoring platform. This research collaboration produced the foundational technology deployed in ICU settings. OUCRU published research documentation on the platform's capabilities for disease characterization and patient management during pandemic conditions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Oxford University through OUCRU provided clinical research validation and academic oversight for the iParamed platform development. The university's involvement established the scientific credibility and clinical evidence foundation for the technology.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Clinical implementation site where advisory board member Dr. Nguyễn Văn Sĩ serves as Deputy Head of Cardiology. Hospital serves as clinical expertise reference and advisory contributor for cardiovascular solutions.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

iRhythm is a US-based cardiac monitoring company (Zio ECG patch) that, like iParamed, focuses on continuous ECG/vital-sign capture and cloud-based clinician workflows. It is the closest direct comparable for iParamed's BIO RHYTHM and BIO CARDICARE offerings.

TypeDirect peer
Description

VivaLNK provides connected wearable vital-sign sensors (ECG, temperature, SpO2) and a platform for RPM and clinical research. It is a direct comparable on the IoMT device-and-platform stack that iParamed builds.

TypeDirect peer
Description

Eko makes digital stethoscopes and connected ECG sensors with AI-assisted cardiac analysis and tele-cardiology workflows. It overlaps iParamed on FDA-cleared multi-vital devices, cloud capture, and AI clinical decision support.

TypeDirect peer
Description

Preventice, now part of Boston Scientific, offers BodyGuardian remote cardiac monitors and clinician monitoring services, directly comparable to iParamed's BIO RHYTHM and BIO TELECARE continuous monitoring use cases.

TypeDirect peer
Description

AliveCor builds FDA-cleared, connected ECG hardware (KardiaMobile) and a clinician cloud platform, mirroring iParamed's combination of FDA-cleared medical devices and an IoMT cloud platform for cardiac assessment.

TypeEmerging player
Description

Vitls is a smaller startup offering a continuous remote vital-sign wearable platform focused on clinical and research use. It overlaps iParamed's IoMT continuous monitoring model at an earlier commercialization stage.

TypeBroad incumbent
Description

GE HealthCare offers patient monitoring, ICU surveillance, and remote care solutions to hospitals worldwide. As a broad incumbent in hospital monitoring, it represents an alternative that established Vietnamese hospitals already buy from.

TypeDirect peer
Description

BioTelemetry, now part of Philips, operates one of the largest remote cardiac monitoring service networks globally using connected ECG patches and Holter devices. It directly parallels iParamed's remote ECG Holter and cardiac risk-monitoring value proposition.

TypeBroad incumbent
Description

Philips is a global incumbent whose RPM and tele-ICU portfolio overlaps with iParamed's continuous monitoring and clinical decision support capabilities, though Philips operates across many other modalities rather than focusing on Vietnamese hospital RPM.

TypeRegional player
Description

VinBrain is a Vietnam-based healthcare AI company serving local hospitals with imaging and clinical decision tools. It is a regional comparable because it targets the same Vietnamese hospital customer base with adjacent AI-driven clinical workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iParamed

Remote Patient Monitoringiparamed.com

iParamed (BioSenses) is a Vietnam-based health-tech company that operates an FDA- and CE-certified IoMT platform for continuous remote patient monitoring, selling bundled hardware, software, and clinical services to hospitals and specialty clinics in Vietnam.

What iParamed does

iParamed, operating commercially under the BioSenses brand, is a Vietnam-based medical technology company that builds an Internet of Medical Things (IoMT) platform for continuous remote patient monitoring. The platform connects FDA- and CE-certified medical devices (ECG Holter, SpO2, blood pressure) to a cloud backend that synchronizes vital-sign data in real time, feeding patient-facing apps, a clinician portal, and early-warning alerts. The core technology originated during COVID-19 as a research collaboration with OUCRU (Oxford University Clinical Research Unit) and was deployed across hundreds of ICU beds, accumulating 30,000+ hours of analyzed vital-sign data and 2,000+ clinical monitoring sessions.

The company packages the underlying platform into five commercial solution lines — BIO SLEEPCARE (sleep apnea screening), BIO RHYTHM (continuous cardiovascular monitoring and risk stratification), BIO CARDICARE (multi-device cardiac and exercise screening), BIO TELECARE (remote tele-monitoring programs), and BIO RESEARCH (clinical research data platform) — and sells them as a bundled offering of hardware, software subscription, and clinical implementation services. Go-to-market is direct enterprise sales to Vietnamese hospitals and specialty clinics (sleep centers, cardiology, respiratory), supported by an advisory board of senior Vietnamese clinicians and a website-driven inside-sales funnel with 24-hour follow-up.

The business is privately held, headquartered in Vietnam, with 7 employees and no disclosed external funding, parent company, or revenue figures. Customer logos are limited (FPT Polytechnic, MedArmor, Nguyen Trai Hospital), and the full device ecosystem carries FDA, CE, and Vietnam Ministry of Health approvals — a regulatory posture that, while heavyweight for a company of this size, also signals readiness for any eventual geographic expansion beyond the single domestic market currently served.

iParamed firmographics

Firmographics
Name
iParamed
Legal name
BioSenses
Website
https://iparamed.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
iParamed (BioSenses) is a Vietnam-based health-tech company that operates an FDA- and CE-certified IoMT platform for continuous remote patient monitoring, selling bundled hardware, software, and clinical services to hospitals and specialty clinics in Vietnam.
Ownership category
akta.pro rank

iParamed industry classification

Industry
Product category
Remote Patient Monitoring
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAH
Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Remote patient monitoring
  • IoMT platform
  • Clinical telemedicine
  • Vital sign monitoring
  • Connected medical devices

iParamed business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Others

Revenue model

  1. Medical Device Sales: Sale of FDA, CE certified medical devices including ECG Holter, SpO2 monitors, and blood pressure devices integrated with the platform
  2. Software Platform Subscription: Cloud-based platform subscription for remote patient monitoring, data analysis, and clinical support services
  3. Professional Services: Clinical implementation support, training, and professional services for healthcare facilities deploying remote monitoring solutions

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

iParamed product offering

Product offering

Core offering

iParamed (operating as BioSenses) provides an IoMT (Internet of Medical Things) remote health monitoring platform that integrates FDA/CE-certified medical devices (ECG Holter, SpO2, blood pressure monitors) with cloud-based software for real-time vital sign collection, synchronization, and clinical decision support. The platform enables continuous patient monitoring across hospitals, specialty clinics, and home environments, with bundled solutions covering sleep apnea screening, cardiac monitoring, tele-monitoring, and clinical research.

Product overview

iParamed, through its BioSenses platform, operates as a unified remote health monitoring ecosystem combining medical devices, IoMT connectivity, and cloud-based data management. The platform consists of a core BioSenses platform with multiple specialized solutions: BIO SLEEPCARE™ for sleep apnea screening, BIO RHYTHM™ for continuous cardiovascular monitoring, BIO CARDICARE™ for multi-device cardiac screening, BIO TELECARE™ for tele-monitoring programs, and BIO RESEARCH™ for clinical research. The closed-loop ecosystem connects medical devices to a unified platform enabling real-time vital sign collection and synchronization, supporting healthcare facilities in maintaining continuous patient monitoring from clinic to home.

Differentiator

Problem solved

Functional benefit

Products and services

  • BioSenses Platform

Quantifiable outcome

  • 30,000+ hours of ECG and vital sign data analyzed
  • +2 more outcomes

Companies that use iParamed

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

iParamed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

iParamed partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • OUCRU (Oxford University Clinical Research Unit)coreStrategic or Co-development PartnerOUCRU (Đơn vị Nghiên cứu Lâm sàng của Đại học Oxford) partnered with iParamed during COVID-19 to develop remote patient monitoring platform. This research collaboration produced the foundational technology deployed in ICU settings. OUCRU published research documentation on the platform's capabilities for disease characterization and patient management during pandemic conditions.
  • Oxford UniversitycoreStrategic or Co-development PartnerOxford University through OUCRU provided clinical research validation and academic oversight for the iParamed platform development. The university's involvement established the scientific credibility and clinical evidence foundation for the technology.
  • Nguyễn Trãi HospitalminorImplementation/ SI/ Consulting PartnerClinical implementation site where advisory board member Dr. Nguyễn Văn Sĩ serves as Deputy Head of Cardiology. Hospital serves as clinical expertise reference and advisory contributor for cardiovascular solutions.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

iParamed competitors and assessment

Company assessment

Direct peers

  • iRhythm Technologies: iRhythm is a US-based cardiac monitoring company (Zio ECG patch) that, like iParamed, focuses on continuous ECG/vital-sign capture and cloud-based clinician workflows. It is the closest direct comparable for iParamed's BIO RHYTHM and BIO CARDICARE offerings.
  • VivaLNK: VivaLNK provides connected wearable vital-sign sensors (ECG, temperature, SpO2) and a platform for RPM and clinical research. It is a direct comparable on the IoMT device-and-platform stack that iParamed builds.
  • Eko Health: Eko makes digital stethoscopes and connected ECG sensors with AI-assisted cardiac analysis and tele-cardiology workflows. It overlaps iParamed on FDA-cleared multi-vital devices, cloud capture, and AI clinical decision support.
  • Preventice Solutions (Boston Scientific): Preventice, now part of Boston Scientific, offers BodyGuardian remote cardiac monitors and clinician monitoring services, directly comparable to iParamed's BIO RHYTHM and BIO TELECARE continuous monitoring use cases.
  • AliveCor: AliveCor builds FDA-cleared, connected ECG hardware (KardiaMobile) and a clinician cloud platform, mirroring iParamed's combination of FDA-cleared medical devices and an IoMT cloud platform for cardiac assessment.
  • BioTelemetry (Philips): BioTelemetry, now part of Philips, operates one of the largest remote cardiac monitoring service networks globally using connected ECG patches and Holter devices. It directly parallels iParamed's remote ECG Holter and cardiac risk-monitoring value proposition.

Emerging players

  • Vitls: Vitls is a smaller startup offering a continuous remote vital-sign wearable platform focused on clinical and research use. It overlaps iParamed's IoMT continuous monitoring model at an earlier commercialization stage.

Broad incumbents

  • GE HealthCare: GE HealthCare offers patient monitoring, ICU surveillance, and remote care solutions to hospitals worldwide. As a broad incumbent in hospital monitoring, it represents an alternative that established Vietnamese hospitals already buy from.
  • Philips Healthcare (RPM): Philips is a global incumbent whose RPM and tele-ICU portfolio overlaps with iParamed's continuous monitoring and clinical decision support capabilities, though Philips operates across many other modalities rather than focusing on Vietnamese hospital RPM.

Regional players

  • VinBrain: VinBrain is a Vietnam-based healthcare AI company serving local hospitals with imaging and clinical decision tools. It is a regional comparable because it targets the same Vietnamese hospital customer base with adjacent AI-driven clinical workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

iParamed social profiles

Digital presence

iParamed compliance and trust

Trust signal

Compliance3 records

iParamed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iParamed leadership team

Management profile

Number of profiles

Profiles3 records

iParamed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iParamed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iParamed

What does iParamed do?

iParamed (operating as BioSenses) provides an IoMT (Internet of Medical Things) remote health monitoring platform that integrates FDA/CE-certified medical devices (ECG Holter, SpO2, blood pressure monitors) with cloud-based software for real-time vital sign collection, synchronization, and clinical decision support. The platform enables continuous patient monitoring across hospitals, specialty clinics, and home environments, with bundled solutions covering sleep apnea screening, cardiac monitoring, tele-monitoring, and clinical research.

Is iParamed a public or private company?

iParamed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was iParamed founded?

iParamed was founded in -1. It employs 1 to 10 people.

How does iParamed make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are software Platform Subscription and professional Services.

Who are iParamed's main competitors?

Direct peers on record are iRhythm Technologies, VivaLNK, Eko Health, Preventice Solutions (Boston Scientific), AliveCor and BioTelemetry (Philips). Vitls is listed as an emerging player. Broad incumbents are GE HealthCare and Philips Healthcare (RPM). VinBrain is listed as a regional player.

Does iParamed have an API?

No public API is recorded for iParamed.

What industry is iParamed in?

iParamed's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLAHACAH, Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales